Anastasia Xagara

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 15

Top Topics

Peritoneal Dialysis

Circulating Tumor Cells

Prognostic Factors

Ejection Fraction

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Anastasia Xagara, Maria Goulielmaki, Sotirios P Fortis, Alexandros Kokkalis, Evangelia Chantzara, George Christodoulopoulos, Ioannis Samaras, Emmanouil Saloustros, Konstantinos Tsapakidis, Vasileios Papadopoulos, Ioannis S Pateras, Vassilis Georgoulias, Constantin N Baxevanis, Athanasios Κotsakis
Pre-Existing Immunity Predicts Response to First-Line Immunotherapy in Non-Small Cell Lung Cancer Patients. Cancers 16 (13) (2024)
Argyro Roumeliotou, Areti Strati, Foteini Chamchougia, Anastasia Xagara, Victoria Tserpeli, Stavroula Smilkou, Elina Lagopodi, Athina Christopoulou, Emmanouil Kontopodis, Ioannis Drositis, Nikolaos Androulakis, Vassilis Georgoulias, Filippos Koinis, Athanasios Κotsakis, Evi S Lianidou, Galatea Kallergi
Comprehensive Analysis of CXCR4, JUNB, and PD-L1 Expression in Circulating Tumor Cells (CTCs) from Prostate Cancer Patients. Cells 13 (9) (2024)
Anastasia Xagara, Argyro Roumeliotou, Alexandros Kokkalis, Konstantinos Tsapakidis, Dimitris Papakonstantinou, Vassilis Papadopoulos, Ioannis Samaras, Evagelia Chantzara, Galatea Kallergi, Athanasios Κotsakis
ES-SCLC Patients with PD-L1 + CTCs and High Percentages of CD8 + PD-1 + T Cells in Circulation Benefit from Front-Line Immunotherapy Treatment. Biomedicines 12 (1) (2024)
Argyro Roumeliotou, Areti Strati, Foteini Chamchougia, Anastasia Xagara, Victoria Tserpeli, Stavroula Smilkou, Elina Lagopodi, Athina Christopoulou, Emmanouil Kontopodis, Ioannis Drositis, Nikolaos Androulakis, Vassilis Georgoulias, Filippos Koinis, Athanasios Κotsakis, Evi S Lianidou, Galatea Kallergi
Comprehensive Analysis of CXCR4, JUNB, and PD-L1 Expression in Circulating Tumor Cells (CTCs) from Prostate Cancer Patients. Cells 13 (9) (2024)
Anastasia Xagara, Argyro Roumeliotou, Alexandros Kokkalis, Konstantinos Tsapakidis, Dimitris Papakonstantinou, Vassilis Papadopoulos, Ioannis Samaras, Evagelia Chantzara, Galatea Kallergi, Athanasios Κotsakis
ES-SCLC Patients with PD-L1 + CTCs and High Percentages of CD8 + PD-1 + T Cells in Circulation Benefit from Front-Line Immunotherapy Treatment. Biomedicines 12 (1) (2024)
Anastasia Xagara, Maria Goulielmaki, Sotirios P Fortis, Alexandros Kokkalis, Evangelia Chantzara, George Christodoulopoulos, Ioannis Samaras, Emmanouil Saloustros, Konstantinos Tsapakidis, Vasileios Papadopoulos, Ioannis S Pateras, Vassilis Georgoulias, Constantin N Baxevanis, Athanasios Κotsakis
Pre-Existing Immunity Predicts Response to First-Line Immunotherapy in Non-Small Cell Lung Cancer Patients. Cancers 16 (13) (2024)
Argyro Roumeliotou, Areti Strati, Foteini Chamchougia, Anastasia Xagara, Victoria Tserpeli, Stavroula Smilkou, Elina Lagopodi, Athina Christopoulou, Emmanouil Kontopodis, Ioannis Drositis, Nikolaos Androulakis, Vassilis Georgoulias, Filippos Koinis, Athanasios Κotsakis, Evi S Lianidou, Galatea Kallergi
Comprehensive Analysis of CXCR4, JUNB, and PD-L1 Expression in Circulating Tumor Cells (CTCs) from Prostate Cancer Patients. Cells 13 (9) (2024)
Vasileios Vardas, Anastasios Tolios, Athina Christopoulou, Vassilis Georgoulias, Anastasia Xagara, Filippos Koinis, Athanasios Κotsakis, Galatea Kallergi
Immune Checkpoint and EMT-Related Molecules in Circulating Tumor Cells (CTCs) from Triple Negative Breast Cancer Patients and Their Clinical Impact. Cancers 15 (7) (2023)
Vasileios Vardas, Julia A Ju, Athina Christopoulou, Anastasia Xagara, Vassilis Georgoulias, Athanasios Κotsakis, Catherine Alix-Panabières, Stuart S Martin, Galatea Kallergi
Functional Analysis of Viable Circulating Tumor Cells from Triple-Negative Breast Cancer Patients Using TetherChip Technology. Cells 12 (15) (2023)
Filippos Koinis, Evangelia Chantzara, Samarinas Michael, Anastasia Xagara, Zisis Kratiras, Vasiliki Leontopoulou, Athanasios Κotsakis
Emerging Role of YAP and the Hippo Pathway in Prostate Cancer. Biomedicines 10 (11) (2022)
Argyro Roumeliotou, Evangelia Pantazaka, Anastasia Xagara, Foteinos-Ioannis D Dimitrakopoulos, Angelos Koutras, Athina Christopoulou, Theodoros Kourelis, Nada H Aljarba, Saad AlKahtani, Filippos Koinis, Athanasios Κotsakis, Galatea Kallergi
Phenotypic Characterization of Circulating Tumor Cells Isolated from Non-Small and Small Cell Lung Cancer Patients. Cancers 15 (1) (2022)
Argyro Roumeliotou, Evangelia Pantazaka, Anastasia Xagara, Foteinos-Ioannis D Dimitrakopoulos, Angelos Koutras, Athina Christopoulou, Theodoros Kourelis, Nada H Aljarba, Saad AlKahtani, Filippos Koinis, Athanasios Κotsakis, Galatea Kallergi
Phenotypic Characterization of Circulating Tumor Cells Isolated from Non-Small and Small Cell Lung Cancer Patients. Cancers 15 (1) (2022)
Argyro Roumeliotou, Evangelia Pantazaka, Anastasia Xagara, Foteinos-Ioannis D Dimitrakopoulos, Angelos Koutras, Athina Christopoulou, Theodoros Kourelis, Nada H Aljarba, Saad AlKahtani, Filippos Koinis, Athanasios Κotsakis, Galatea Kallergi
Phenotypic Characterization of Circulating Tumor Cells Isolated from Non-Small and Small Cell Lung Cancer Patients. Cancers 15 (1) (2022)
Argyro Roumeliotou, Evangelia Pantazaka, Anastasia Xagara, Foteinos-Ioannis D Dimitrakopoulos, Angelos Koutras, Athina Christopoulou, Theodoros Kourelis, Nada H Aljarba, Saad AlKahtani, Filippos Koinis, Athanasios Κotsakis, Galatea Kallergi
Phenotypic Characterization of Circulating Tumor Cells Isolated from Non-Small and Small Cell Lung Cancer Patients. Cancers 15 (1) (2022)
Filippos Koinis, Anastasia Xagara, Evangelia Chantzara, Vassiliki Leontopoulou, Chrissovalantis Aidarinis, Athanasios Κotsakis
Myeloid-Derived Suppressor Cells in Prostate Cancer: Present Knowledge and Future Perspectives. Cells 11 (1) (2021)